Independent Director Samir Dhawan resigned from the board of Kerala Ayurveda Limited effective June 09, 2026, due to other professional commitments requiring increased time and attention. The resignation was submitted via a letter dated June 09, 2026, and became effective at the close of business hours on the same day. Dhawan confirmed that there are no other material reasons for his departure besides the stated professional commitments.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding the format of the intimation. George K T, the Chief Financial Officer, signed the disclosure on behalf of the company.

Resignation Details

The company provided specific details regarding the change in board composition in an annexure to the regulatory filing. The table below summarizes the key particulars of the resignation:

Dhawan stated in his resignation letter that he is unable to devote the necessary time to effectively discharge his responsibilities as an Independent Director. He expressed gratitude to the Chairperson and board members for their support and cooperation during his tenure. The information has been made available on the company’s investor relations website.

Kerala Ayurveda Limited reported a consolidated net loss of ₹20.65 crore for the financial year ended March 31, 2026, widening from a loss of ₹15.39 crore in the previous year. Revenue from operations for the year rose to ₹1,311.46 crore from ₹1,203.34 crore in FY25. The board approved the audited financial results for the quarter and year ended March 31, 2026, during a meeting held on May 25, 2026. The company submitted newspaper clippings of the extract of these audited financial results to the Bombay Stock Exchange on May 27, 2026, confirming publication in the Financial Express and Deepika.

Financial Performance

For the quarter ended March 31, 2026, the company reported a consolidated net loss of ₹9.16 crore, compared to a loss of ₹16.46 crore in the same period last year. Total income for the quarter stood at ₹366.43 crore. On a standalone basis, the net loss for FY26 was ₹14.74 crore, compared to ₹13.78 crore in the previous year, with total income increasing to ₹1,034.20 crore from ₹778.61 crore.

Auditor Appointments

The board appointed Mr. Alphonse Scaria as the Internal Auditor for FY 2026-27. Additionally, M/s. SLR & Associates, Kochi, was appointed as the Cost Auditor for the same period. These appointments were made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Auditor's Report

M/s. G. Joseph & Associates, Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion on the standalone and consolidated financial results. However, the auditors drew attention to significant trade receivables due from the company's subsidiaries, noting that a substantial portion has been outstanding for more than six months. Management represented that these amounts are fully recoverable, and no provision for expected credit loss was recognised.

The trading window for dealing in the company's securities, which closed on March 31, 2026, will remain shut until 48 hours after the financial results are made public.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE817B01025/843d58ac-4cc1-4d1e-8e7a-23ac38d171dc.pdf